Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/28907
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVermersch, Patrick-
dc.contributor.authorColes, Alasdair J.-
dc.contributor.authorBoyko, Alexey N.-
dc.contributor.authorDe Seze, Jerome-
dc.contributor.authorHartung, Hans-Peter-
dc.contributor.authorHavrdova, Eva-
dc.contributor.authorInshasi, Jihad Said-
dc.contributor.authorMcCombe, Pamela-
dc.contributor.authorMontalban, Xavier-
dc.contributor.authorPozzilli, Carlo-
dc.contributor.authorSelmaj, Krzysztof W.-
dc.contributor.authorMargolin, David H.-
dc.contributor.authorMelanson, Maria-
dc.contributor.authorDaizadeh, Nadia-
dc.contributor.authorRodriguez, Claudio E.-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.date.accessioned2019-08-07T14:36:05Z-
dc.date.available2019-08-07T14:36:05Z-
dc.date.issued2018-
dc.identifier.citationNEUROLOGY, 90(supl.15) (Art N° P6.376)-
dc.identifier.issn0028-3878-
dc.identifier.urihttp://hdl.handle.net/1942/28907-
dc.description.sponsorshipStudy Supported by: Sanofi and Bayer HealthCare Pharmaceuticals.-
dc.language.isoen-
dc.publisherLIPPINCOTT WILLIAMS & WILKINS-
dc.rights2018, American Academy of Neurology-
dc.titleDurable Clinical Efficacy of Alemtuzumab in Patients With Active RRMS in the Absence of Continuous Treatment: 7-Year Follow-up of CARE-MS I Patients (TOPAZ Study)-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateAPR 21-27, 2018-
local.bibliographicCitation.conferencename70th Annual Meeting of the American-Academy-of-Neurology (AAN)-
local.bibliographicCitation.conferenceplaceLos Angeles, CA-
dc.identifier.issuesupl.15-
dc.identifier.volume90-
local.format.pages4-
local.bibliographicCitation.jcatM-
dc.description.notes[Vermersch, Patrick] Univ Lille, Lille, France. [Coles, Alasdair J.] Univ Cambridge, Sch Med, Cambridge, England. [Boyko, Alexey N.] Pirogov Russian Natl Res Univ, Moscow, Russia. [Boyko, Alexey N.] Usupov Hosp, Demyelinating Dis Ctr, Moscow, Russia. [De Seze, Jerome] Univ Strasbourg, Strasbourg, France. [Hartung, Hans-Peter] Heinrich Heine Univ, Dusseldorf, Germany. [Havrdova, Eva] Charles Univ Prague, Fac Med 1, Prague, Czech Republic. [Inshasi, Jihad Said] Rashid Hosp, Dubai, U Arab Emirates. [Inshasi, Jihad Said] Dubai Med Coll, Dubai, U Arab Emirates. [McCombe, Pamela] Univ Queensland, Brisbane, Qld, Australia. [Montalban, Xavier] Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya Cemcat, Barcelona, Spain. [Montalban, Xavier] Univ Toronto, St Michaels Hosp, Barcelona, Spain. [Pozzilli, Carlo] Univ Rome, Rome, Italy. [Selmaj, Krzysztof W.] Med Univ Lodz, Lodz, Poland. [Margolin, David H.; Melanson, Maria; Daizadeh, Nadia; Rodriguez, Claudio E.] Sanofi, Cambridge, MA USA. [Van Wijmeersch, Bart] Hasselt Univ, Rehabilitat & MS Ctr Overpelt, BIOMED, Hasselt, Belgium.-
local.publisher.placePHILADELPHIA-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnrP6.376-
dc.identifier.isi000453090805112-
item.fulltextWith Fulltext-
item.contributorVermersch, Patrick-
item.contributorColes, Alasdair J.-
item.contributorBoyko, Alexey N.-
item.contributorDe Seze, Jerome-
item.contributorHartung, Hans-Peter-
item.contributorHavrdova, Eva-
item.contributorInshasi, Jihad Said-
item.contributorMcCombe, Pamela-
item.contributorMontalban, Xavier-
item.contributorPozzilli, Carlo-
item.contributorSelmaj, Krzysztof W.-
item.contributorMargolin, David H.-
item.contributorMelanson, Maria-
item.contributorDaizadeh, Nadia-
item.contributorRodriguez, Claudio E.-
item.contributorVAN WIJMEERSCH, Bart-
item.fullcitationVermersch, Patrick; Coles, Alasdair J.; Boyko, Alexey N.; De Seze, Jerome; Hartung, Hans-Peter; Havrdova, Eva; Inshasi, Jihad Said; McCombe, Pamela; Montalban, Xavier; Pozzilli, Carlo; Selmaj, Krzysztof W.; Margolin, David H.; Melanson, Maria; Daizadeh, Nadia; Rodriguez, Claudio E. & VAN WIJMEERSCH, Bart (2018) Durable Clinical Efficacy of Alemtuzumab in Patients With Active RRMS in the Absence of Continuous Treatment: 7-Year Follow-up of CARE-MS I Patients (TOPAZ Study). In: NEUROLOGY, 90(supl.15) (Art N° P6.376).-
item.accessRightsRestricted Access-
crisitem.journal.issn0028-3878-
crisitem.journal.eissn1526-632X-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Durable Clinical Efficacy of Alemtuzumab in Patients With Active RRMS in the Absence of Continuous Treatment_ 7-Year Follow-up of CARE-MS I Patients (TOPAZ Study) (P6.376) _ Neurology.pdf
  Restricted Access		Published version3.04 MBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.